IN BRIEF: Yourgene Health partners with Cytox to run Alzheimer's test

Yourgene Health PLC - Manchester, England-headquartered molecular diagnostics firm - Signs ...

Alliance News 11 March, 2021 | 9:12PM
Email Form Facebook Twitter LinkedIn RSS

Yourgene Health PLC - Manchester, England-headquartered molecular diagnostics firm - Signs contract with partner Cytox Ltd for Yourgene Genomic Services to run Cytox's genetic test, genoSCORE-LAB, which can predict the risk of someone's cognitive decline due to Alzheimer's disease.

The test uses a blood or saliva sample to conduct testing.

"We are pleased to update shareholders on this exciting development with our partner Cytox, highlighting the strengths and scope of our YGS capabilities. This is an additional test in our growing portfolio around precision health and provides another endorsement of the CRO core services offering YGS provides to our partners," notes Chief Executive Officer Lyn Rees.

Current stock price: 16.25 pence

Year-to-date change: up 10%

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Yourgene Health PLC

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2025 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures